Clinical trials
Completed Phase 2 Anemia, Refractory trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
42 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 5 |
| 2002 | 1 |
| 2003 | 4 |
| 2005 | 5 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2013 | 1 |
| 2015 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 42 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fred Hutchinson Cancer Center | 6 |
| Roswell Park Cancer Institute | 4 |
| National Cancer Institute (NCI) | 3 |
| Alliance for Clinical Trials in Oncology | 2 |
| Case Comprehensive Cancer Center | 2 |
| H. Lee Moffitt Cancer Center and Research Institute | 2 |
| Masonic Cancer Center, University of Minnesota | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2 |
| Asan Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia, Refractory | 42 |
| Myelodysplastic Syndromes | 35 |
| Anemia, Refractory, with Excess of Blasts | 33 |
| Leukemia | 28 |
| Leukemia, Myelomonocytic, Chronic | 24 |
| Myeloproliferative Disorders | 19 |
| Leukemia, Myeloid, Acute | 16 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 16 |
| Leukemia, Myeloid, Chronic-Phase | 14 |
| Myelodysplastic-Myeloproliferative Diseases | 13 |
Trials
Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.